Use of real-world data for decision making in Canada and United Kingdom-Reference-Cited by-同舟云学术

Use of real-world data for decision making in Canada and United Kingdom

Published:2022-11-17 Issue:3 Volume:2 Page:7-19
ISSN:2782-3784
Container-title:Real-World Data & Evidence
language:
Short-container-title:MyRWD

Author:

Mukhortova P. A.¹^ORCID,Gorkavenko P. V.¹^ORCID,Strunina Yu. V.¹^ORCID,Omelyanovskiy V. V.²^ORCID,Kalinichenko V. V.¹^ORCID

Affiliation:

1. Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

2. Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation; Financial Research Institute of the Ministry of Finance of the Russian Federation; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation

Abstract

This article provides an overview of approaches to the use of real-world data (RWD) and real-world evidence (RWE) in the processes of registration and health technology assessment in Canada and the UK, as well as a brief description of tools for health management decision-making, the Canadian Real-world Evidence for Value in Cancer Collaboration and electronic databases and registries. Information is provided on when RWE submission is possible and recommended, and what requirements the regulatory agencies have for RWD and RWE.

Publisher

Publishing House OKI

Reference33 articles.

1. Kasimova AR, Kolbin AS. Real-world evidence market: key players and key segments. Real-World Data & Evidence. 2022;2 (1):40-3. (In Russ.). https://doi.org/10.37489/2782-3784-myrwd-11.

2. Anandkumar M. Coordination and Continuity Through Electronic Medical Records // Public Heal. Behind Bars. New York, NY: Springer, New York, NY, 2022. Pp. 475-82.

3. Решение Совета Евразийской экономической комиссии от 3 ноября 2016 г. № 78 «О Правилах регистрации и экспертизы лекарственных средств для медицинского применения».

4. Borzova MA. Real-world data: general regulatory approaches in the EU and Japan. Real-World Data & Evidence. 2022;2 (1):11-6. https://doi.org/10.37489/2782-3784-myrwd-7.

5. Kolbin AS, Belousov DYu. A brief report of real-world evidence development (RWD / RWE) in 2021: United States, Russia, and the Eurasian Economic Union (EAEU). Real-World Data & Evidence. 2022;2 (1):1-9. https://doi.org/10.37489/2782-3784-myrwd-6.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world data: principles of use in decision making and in health technology assessment;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2023-07-19